Epoprostenol intravenous - Actelion
At a glance
- Drug Originator GeneraMedix
- Drug Licenced by Accredo Health; Knight Therapeutics
- Drug Class 2 ring heterocyclic compounds; Antihypertensives; Prostaglandins; Small molecules; Vasodilators
- Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
- USA Patent Applicants ACTELION
- USA Patents 2
- NDAs 1
- International Patents 19
- Patent Applications 3,188

Disclaimer